NCT05339100 - Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

March 22, 2022

Primary Completion Date

April 13, 2023

Study Completion Date

April 13, 2023

Conditions

Healthy Participants Study

Interventions

DRUG

Anifrolumab

Participants will receive SC doses anifrolumab via AI or APFS.

DEVICE

Autoinjector

Autoinjector will be use to administer single SC dose of anifrolumab.

DEVICE

Accessorized Pre-Filled Syringe

Accessorized Pre-filled syringe will be use to administer single SC dose of anifrolumab.

Trial Locations (3)

Research Site, Berlin

Research Site, Brooklyn

Research Site, Harrow